Clinical Trial Update: Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a vascular disruption theranostic approach for soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: John O. Prior | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED